Share price
₹5,290 latest close · −19.3% over the last 90 sessions
₹5,290 month-end · −9.9% over 12 months
₹5,290 month-end · −19.8% over 3 years
₹5,290 month-end · +52.6% since Jan '19
52-week range ₹4995.00 to ₹7180.00 · 1-year volatility 26.7%
Was the rally earned?
Earnings helped, the multiple did not.
- Per-share earnings added 44 points, but investors now pay less per rupee of profit (P/E 34.6x to 19.6x), which took 54 points back.
- The share count fell 4%.
Earnings helped, the multiple did not.
- Per-share earnings added 39 points, but investors now pay less per rupee of profit (P/E 37.9x to 19.6x), which took 59 points back.
- The share count barely moved.
Earnings helped, the multiple did not.
- Per-share earnings added 16 points, but investors now pay less per rupee of profit (P/E 39.3x to 19.6x), which took 55 points back.
- The share count barely moved.
What do "pts" mean?
"pts" are percentage points of the share price return. The parts add up to the total shown for each period. Because price = P/E × net profit ÷ share count, higher profit pushes the price up, a higher P/E pushes it up, and more shares push it down.
Example: if the price rose 34% and profit growth accounts for +58 pts while a lower P/E accounts for -24 pts, then 58 - 24 = 34. The +58 is not the profit growth rate itself: it is the part of the price move that profit growth explains.
Net profit is trailing twelve months as reported with a 60-day lag.
How rough has the ride been?
Drawdown from peak
Largest drawdowns
-53.5% (2021-10 peak to 2026-10 low, not yet recovered)
-34.6% (2020-03 peak to 2020-03 low, recovered 2020-08)
-16.5% (2019-06 peak to 2019-09 low, recovered 2019-10)
Most recent volume spikes
2026-10-23: 5.4x the 50-day median, price -7.1% that day
2026-08-07: 5.5x the 50-day median, price -0.3% that day
2026-07-29: 5.3x the 50-day median, price +2.2% that day
Beta is the slope of daily returns against a market-cap-weighted index of the sector's other listed companies, built from today's constituents (so it excludes companies no longer listed).
Is it expensive against its own past and its peers?
Usual range 27.2x to 47.2x since 2019-01.
8% above the Process Industries median.
The chart loads when you open this tab.
The chart loads when you open this tab.
How to read this
Shaded band: 10th to 90th percentile of the company's own P/E history; dotted line: its median; orange line: sector median (companies with a positive multiple, at least 5 in the sector).
Sector figures are built from today's listed companies, so they exclude companies that are no longer listed.
Where does it rank among Process Industries peers?
Each cell is the company's percentile rank among its Process Industries peers (non-financial companies) that month.
Darker is better-ranked.
Rows marked ↓ are inverted (lower debt, shorter cash cycle and a lower P/E rank higher).
Where it ranks today
- ROCE67th▲ 8 pts vs a year ago
- Op. margin85th▲ 6 pts vs a year ago
- Revenue growth69th▼ 5 pts vs a year ago
- EPS growth80thflat vs a year ago
- Debt/equity ↓86thflat vs a year ago
- Cash cycle ↓72nd▲ 13 pts vs a year ago
- P/E ↓47th▲ 18 pts vs a year ago
- 12M momentum50th▼ 4 pts vs a year ago
Rank history
Percentiles use today's listed companies in the sector and need at least 5 peers with a value; grey cells have too few.
ROE is computed from net profit and book value where the source does not report it.
The Process Industries sector page Watch it move against Process Industries in the Observatory
What is the price implying?
At normalised P/E (five-year average earnings) of 30.3x, a holder earning 12%/yr needs earnings to grow about 19.3%/yr for 10 years, then trade at 15x.
Over time
Implied growth by month (solid) and delivered growth (dashed).
Change the assumptions
| Exit P/E / return | 11% | 12% | 13% |
|---|---|---|---|
| 12x | 20.7% | 21.8% | 22.9% |
| 15x | 18.2% | 19.3% | 20.3% |
| 20x | 15.0% | 16.0% | 17.0% |
Drag a slider to test other assumptions
Implied: 19.3%/yrLooking back
- Jan 2020Price implied 25%/yr; EPS has since grown 7%/yr (7.0 yrs)
- Jan 2021Price implied 25%/yr; EPS has since grown 1%/yr (6.0 yrs)
- Jan 2022Price implied 28%/yr; EPS has since grown 2%/yr (5.0 yrs)
Past comparisons cover only companies listed today (survivorship bias) and say nothing about future outcomes.
“Implied growth” is what the current price would require under our stated assumptions, not what we expect. How this is calculated and the market-wide lists.
What prices imply across Process Industries The market-wide Expectations lists
Key figures
- Share Priceclose 9 Nov
- ₹5290.00
- P/E
- 19.6x
- ROCE
- 15.0%
- Market Cap
- ₹15576 cr
- Revenue (TTM)
- ₹6644 cr
- P/S
- 2.3x
- P/B
- 2.5x
- ROE
- 12.8%
- Operating Margin
- 21.0%
- Debt / Equity
- 0.0x
- Promoter Holding
- 45.3%
- 12M Momentum
- -9.9%
52-week range
Price risk
Balance sheet & cash
Are profits backed by cash?
Other income reliance20%Near threshold
Other income as a share of pre-tax profit (trailing twelve months): 20.3%. Bands: below 15%, 15% to 35%, above 35%.
Tax rate27%Within range
Median quarterly effective tax rate over about 2.5 years: 27.0%. Bands: 15% to 35%, 5% to 15% or 35% to 50%, outside 5% to 50%.
Cash conversion1.52xWithin range
Operating cash flow divided by net profit over the last three fiscal years: 1.52x (cash from operations ₹2,293 cr, net profit ₹1,512 cr). Bands: 0.8x and above, 0.5x to 0.8x, below 0.5x.
Free cash flow3 of 5 yrsNear threshold
Fiscal years with positive free cash flow in the last 5: 3. Bands: at least 80% of years, 40% to 80%, below 40%.
Receivable days vs history+2 daysWithin range
Debtor days are above the median of the previous three fiscal years by 2 days (74 vs 72). Bands: under 15 days, 15 to 45, over 45.
Capital work in progress4% of fixed assetsWithin range
Capital work-in-progress is 4% of fixed assets. Bands: not rising or up to 30%; rising for three years and above 30%; rising and above 60%.
Payable days+10 days / 2 yrsWithin range
Days payable changed by +10 over two years. Bands: rise of up to 30 days; more than 30 days.
Tap a check to see how it is measured
How to read this
Each check is a named rule with fixed thresholds, not a score. Annual statements are the latest restated figures, so a past year may differ from what was originally reported.
Who has been buying and selling?
- Over 3 years, DIIs trimmed 0.6 pts.
- The number of shareholders fell from 66,776 to 56,570 (-15%) between Sep 2023 and Jun 2026.
Holdings, Jun '26
How each group changed
Number of shareholders
Quarterly shareholding as reported, labelled by the quarter it covers (it becomes visible about two months later).
Shareholder counts are only available for recent quarters.
What happened next to similar setups
- We found 50 past situations where a non-financial company looked like ATUL LIMITED today on valuation, return on capital, margins, debt, growth, price momentum, size and volatility.
- Over the following 12 months the middle half of them returned −15% to +19% vs the market, against −4% for all non-financial companies in the same months.
- The gap against the base rate (+0.3%, 80% range −9.0% to +4.6%) is within what chance and overlapping periods produce.
Where the 50 outcomes landed
Each dot is one past situation (hover or tap for details) · Solid dots are the closest matches, listed below · Shaded is the middle half of all companies in the same months · 2 beyond the range shown, drawn at the edge
50 past situations · 50 companies · 31 months · 2020–2025
The closest matches
| Company | When | P/E | ROCE | 12M mom. | Drawdown | Next 12 months |
|---|---|---|---|---|---|---|
| FDC Health Technology |
Jan 2024 | 36x | 13% | +57% | −6% | +4% |
| STARCEMENT Producer Manufacturing |
May 2020 | 10x | 18% | −39% | −43% | −14% |
| CARBORUNIV Process Industries |
Sep 2020 | 19x | 18% | −10% | −23% | +101% |
| PERSISTENT Technology Services |
Apr 2020 | 11x | 20% | −25% | −36% | +169% |
| ESCORTS Producer Manufacturing |
Aug 2024 | 40x | 14% | +22% | −11% | 0% |
Show the other 3 matches
| Company | When | P/E | ROCE | 12M mom. | Drawdown | Next 12 months |
|---|---|---|---|---|---|---|
| NATCOPHARM Health Technology |
Jan 2024 | 24x | 18% | +62% | −5% | +25% |
| ZYDUSLIFE Health Technology |
Oct 2023 | 30x | 15% | +32% | −13% | +25% |
| DEEPAKNTR Process Industries |
Jan 2025 | 37x | 22% | +1% | −25% | −33% |
How reliable is this?
Matched on P/E, P/S, ROCE, operating margin, debt/equity, interest cover, revenue growth, 12-month momentum, drawdown from 12-month high, size and volatility. Closest on: 12-month momentum, drawdown from 12-month high and P/S. One match per company and at most 7 from any one month.
Independent periods: the matches fall in 5 distinct 12-month windows. Matches from nearby months share the same market conditions, so fewer windows means less evidence.
What else looks like this?
Companies with the most similar financial profile today, regardless of industry.
Similarity is statistical, based on reported metrics; it does not imply similar business quality or future returns.
What changed?
30 events since Jun '22
- OctPriceFell 54% from the Oct 2021 peak to the Oct 2026 low.
- OctPriceVolume reached 5.4x its 50-day median on 2026-10-23; price -7.1% that day.
- SepValuationP/E fell below the 10th percentile of its own history to date (21.9x).
- JulPriceVolume reached 18.8x its 50-day median on 2026-07-24; price +4.5% that day.
- AprPriceVolume reached 15.0x its 50-day median on 2026-04-24; price -0.7% that day.
- MarPriceVolume reached 5.8x its 50-day median on 2026-03-24; price +0.3% that day.
- OctPriceVolume reached 15.6x its 50-day median on 2025-10-17; price +2.1% that day.
- SepPeer rankMoved into the top quartile of Process Industries on operating margin (from the 2nd quartile).
Show 22 earlier events
- JulPeer rankSlipped to the 2nd quartile of Process Industries on operating margin (from the top quartile).
- JulPriceVolume reached 6.0x its 50-day median on 2025-07-18; price -4.6% that day.
- JunResultsYear-on-year EPS growth turned positive.
- JunPeer rankMoved into the 2nd quartile of Process Industries on ROCE (from the 3rd quartile).
- MayValuationP/E crossed above the 90th percentile of its own history to date (50.5x).
- AprPriceVolume reached 17.0x its 50-day median on 2025-04-11; price +10.2% that day.
- JanPriceVolume reached 8.6x its 50-day median on 2025-01-24; price -3.0% that day.
- OctPriceVolume reached 7.8x its 50-day median on 2024-10-25; price -3.1% that day.
- JulPriceVolume reached 10.5x its 50-day median on 2024-07-19; price -2.5% that day.
- JunValuationP/E crossed above the 90th percentile of its own history to date (59.1x).
- JunPeer rankSlipped to the 3rd quartile of Process Industries on ROCE (from the 2nd quartile).
- AprPriceVolume reached 6.4x its 50-day median on 2024-04-10; price +5.4% that day.
- OctPriceVolume reached 5.8x its 50-day median on 2023-10-23; price -4.3% that day.
- JulPriceVolume reached 11.9x its 50-day median on 2023-07-21; price +6.6% that day.
- JunResultsRevenue (TTM) reached a new high of ₹5,428 cr.
- JunPeer rankMoved into the 3rd quartile of Process Industries on EPS growth (from the bottom quartile).
- MayPriceVolume reached 9.9x its 50-day median on 2023-05-02; price -4.1% that day.
- JanPriceVolume reached 6.5x its 50-day median on 2023-01-23; price -3.9% that day.
- JulValuationP/E crossed above the 90th percentile of its own history to date (43.5x).
- JulPriceVolume reached 12.5x its 50-day median on 2022-07-22; price +5.5% that day.
- JunResultsRevenue (TTM) reached a new high of ₹5,081 cr.
- JunPeer rankSlipped to the 2nd quartile of Process Industries on ROCE (from the top quartile).
Events are generated from the data by fixed rules.
The month shown is when the change became visible in the reported figures, assuming a 60-day lag after each quarter end; it is not an announcement date.
Where price and fundamentals disagree, market-wide Rewind the whole market to any month
Monthly history60 months · 2021-12 to 2026-11
| Month | P/E | Revenue (TTM) | ROE | ROCE | Debt / Equity |
|---|---|---|---|---|---|
| 2026-11 | 19.6x | ₹6644 cr | 12.8% | 15.0% | 0.0x |
| 2026-10 | 18.6x | ₹6644 cr | 13.0% | 15.0% | 0.0x |
| 2026-09 | 21.9x | ₹6644 cr | 13.0% | 15.0% | 0.0x |
| 2026-08 | 27.8x | ₹6274 cr | 11.1% | 15.0% | 0.0x |
| 2026-07 | 29.3x | ₹6274 cr | 11.1% | 15.0% | 0.0x |
| 2026-06 | 28.1x | ₹6274 cr | 11.1% | 15.0% | 0.0x |
| 2026-05 | 34.0x | ₹6056 cr | 10.9% | 13.0% | 0.0x |
| 2026-04 | 33.8x | ₹6056 cr | 10.9% | 13.0% | 0.0x |
| 2026-03 | 31.6x | ₹6056 cr | 10.9% | 13.0% | 0.0x |
| 2026-02 | 36.2x | ₹5899 cr | 10.0% | 13.0% | 0.0x |
| 2026-01 | 33.7x | ₹5899 cr | 10.0% | 13.0% | 0.0x |
| 2025-12 | 33.3x | ₹5899 cr | 10.0% | 13.0% | 0.0x |
| 2025-11 | 34.6x | ₹5740 cr | 9.3% | 13.0% | 0.0x |
| 2025-10 | 33.9x | ₹5740 cr | 9.3% | 13.0% | 0.0x |
| 2025-09 | 35.7x | ₹5740 cr | 9.3% | 13.0% | 0.0x |
| 2025-08 | 38.2x | ₹5584 cr | 8.9% | 13.0% | 0.0x |
| 2025-07 | 40.3x | ₹5584 cr | 8.9% | 13.0% | 0.0x |
| 2025-06 | 45.5x | ₹5584 cr | 8.9% | 13.0% | 0.0x |
| 2025-05 | 50.5x | ₹5344 cr | 8.4% | 9.0% | 0.0x |
| 2025-04 | 47.8x | ₹5344 cr | 8.4% | 9.0% | 0.0x |
| 2025-03 | 43.4x | ₹5344 cr | 8.4% | 9.0% | 0.0x |
| 2025-02 | 41.4x | ₹5065 cr | 7.5% | 9.0% | 0.0x |
| 2025-01 | 49.0x | ₹5065 cr | 7.5% | 9.0% | 0.0x |
| 2024-12 | 54.2x | ₹5065 cr | 7.5% | 9.0% | 0.0x |
| 2024-11 | 64.9x | ₹4866 cr | 6.5% | 9.0% | 0.0x |
| 2024-10 | 69.7x | ₹4866 cr | 6.5% | 9.0% | 0.0x |
| 2024-09 | 68.4x | ₹4866 cr | 6.5% | 9.0% | 0.0x |
| 2024-08 | 72.6x | ₹4726 cr | 6.3% | 9.0% | 0.0x |
| 2024-07 | 72.6x | ₹4726 cr | 6.3% | 9.0% | 0.0x |
| 2024-06 | 59.1x | ₹4726 cr | 6.3% | 9.0% | 0.0x |
| 2024-05 | 32.3x | ₹5428 cr | 10.9% | 15.0% | 0.0x |
| 2024-04 | 34.4x | ₹5428 cr | 10.9% | 15.0% | 0.0x |
| 2024-03 | 33.0x | ₹5428 cr | 10.9% | 15.0% | 0.0x |
| 2024-02 | 35.7x | ₹5428 cr | 10.9% | 15.0% | 0.0x |
| 2024-01 | 36.9x | ₹5428 cr | 10.9% | 15.0% | 0.0x |
| 2023-12 | 41.1x | ₹5428 cr | 10.9% | 15.0% | 0.0x |
| 2023-11 | 37.9x | ₹5428 cr | 10.9% | 15.0% | 0.0x |
| 2023-10 | 35.8x | ₹5428 cr | 10.9% | 15.0% | 0.0x |
| 2023-09 | 40.4x | ₹5428 cr | 10.9% | 15.0% | 0.0x |
| 2023-08 | 42.1x | ₹5428 cr | 10.9% | 15.0% | 0.0x |
| 2023-07 | 39.0x | ₹5428 cr | 10.9% | 15.0% | 0.0x |
| 2023-06 | 40.2x | ₹5428 cr | 10.9% | 15.0% | 0.0x |
| 2023-05 | 33.0x | ₹5081 cr | 13.7% | 19.0% | 0.0x |
| 2023-04 | 33.6x | ₹5081 cr | 13.7% | 19.0% | 0.0x |
| 2023-03 | 34.1x | ₹5081 cr | 13.7% | 19.0% | 0.0x |
| 2023-02 | 34.4x | ₹5081 cr | 13.7% | 19.0% | 0.0x |
| 2023-01 | 34.9x | ₹5081 cr | 13.7% | 19.0% | 0.0x |
| 2022-12 | 40.4x | ₹5081 cr | 13.7% | 19.0% | 0.0x |
| 2022-11 | 41.0x | ₹5081 cr | 13.7% | 19.0% | 0.0x |
| 2022-10 | 41.0x | ₹5081 cr | 13.7% | 19.0% | 0.0x |
| 2022-09 | 44.2x | ₹5081 cr | 13.7% | 19.0% | 0.0x |
| 2022-08 | 44.9x | ₹5081 cr | 13.7% | 19.0% | 0.0x |
| 2022-07 | 43.5x | ₹5081 cr | 13.7% | 19.0% | 0.0x |
| 2022-06 | 39.3x | ₹5081 cr | 13.7% | 19.0% | 0.0x |
| 2022-05 | 36.7x | ₹3731 cr | 17.2% | 24.0% | 0.0x |
| 2022-04 | 40.4x | ₹3731 cr | 17.2% | 24.0% | 0.0x |
| 2022-03 | 46.4x | ₹3731 cr | 17.2% | 24.0% | 0.0x |
| 2022-02 | 41.8x | ₹3731 cr | 17.2% | 24.0% | 0.0x |
| 2022-01 | 43.1x | ₹3731 cr | 17.2% | 24.0% | 0.0x |
| 2021-12 | 40.8x | ₹3731 cr | 17.2% | 24.0% | 0.0x |
Older months are in the live observatory.